IOVA — Iovance Biotherapeutics Share News
0.000.00%
Last trade - 00:00- $6.67bn
- $6.37bn
- $263.50m
Iovance Biotherapeutics Inc expected to post a loss of 24 cents a share - Earnings Preview
Brief: Iovance Biotherapeutics reports inducement grants under Nasdaq listing rule 5635(C)(4)
U.S. RESEARCH ROUNDUP-Autodesk, Coca-Cola, NetApp
Iovance Biotherapeutics Inc reports results for the quarter ended December 31 - Earnings Summary
Brief: Iovance Biotherapeutics Q4 Net Income USD -78.559 Million
Brief: Iovance Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Iovance Biotherapeutics Inc reports results for the quarter ended in September 30 - Earnings Summary
Brief: Iovance Biotherapeutics Q3 Net Income USD -83.541 Million
Iovance Biotherapeutics Inc expected to post a loss of 30 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Revance Therapeutics, Insulet, StepStone
U.S. STOCKS ON THE MOVE-Synchrony, Grindr, Blend Labs
U.S. STOCKS ON THE MOVE-Doximity, Expedia, Nikola
Iovance Biotherapeutics rises on higher-than-expected revenue forecast
Iovance Biotherapeutics Inc reports results for the quarter ended in June - Earnings Summary
Brief: Iovance Biotherapeutics Q2 Net Income USD -97.101 Million
Iovance Biotherapeutics Inc expected to post a loss of 35 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP- First Hawaiian, Olin, Watsco
U.S. STOCKS ON THE MOVE-Gold miners, Dell, Nutanix
U.S. STOCKS ON THE MOVE-XPO, Howmet Aerospace, Martin Midstream